MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis
Figure 3
Survival analysis of miR-429 expression in strata of AFB1-DNA adducts and tumor size. ((a)-(b)) Tumor recurrence-free survival (RFS) and miR-429 expression in strata of AFB1-DNA adduct levels. ((c)-(d)) Overall survival (OS) and miR-429 expression in strata of AFB1-DNA adduct levels. ((e)-(f)) RFS and miR-429 expression in strata of tumor size. ((g)-(h)) OS and miR-429 expression in strata of tumor size. Cumulative hazard function was plotted by Kaplan-Meier’s methodology, and value was calculated with two-sided log-rank tests. Relative hazard ratio (HR) and corresponding 95% CI of high miR-429 expression (compared with low expression) were calculated using multivariable cox regression model (including all significant variables).
